Subcutaneous adipose cell size and distribution: Relationship to insulin resistance and body fat
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Objective: Metabolic heterogeneity among obese individuals may be attributable to differences in adipose cell size. We sought to clarify this by quantifying adipose cell size distribution, body fat, and insulin‐mediated glucose uptake in overweight to moderately‐obese individuals. Methods: A total of 148 healthy nondiabetic subjects with BMI 25‐38 kg/m 2 underwent subcutaneous adipose tissue biopsies and quantification of insulin‐mediated glucose uptake with steady‐state plasma glucose (SSPG) concentrations during the modified insulin suppression test. Cell size distributions were obtained with Beckman Coulter Multisizer. Primary endpoints included % small adipose cells and diameter of large adipose cells. Cell‐size and metabolic parameters were compared by regression for the whole group, according to insulin‐resistant (IR) and insulin‐sensitive (IS) subgroups, and by body fat quintile. Results: Both large and small adipose cells were present in nearly equal proportions. Percent small cells was associated with SSPG (r = 0.26, P = 0.003). Compared to BMI‐matched IS individuals, IR counterparts demonstrated fewer, but larger large adipose cells, and a greater proportion of small‐to‐large adipose cells. Diameter of the large adipose cells was associated with % body fat (r = 0.26, P = 0.014), female sex (r = 0.21, P = 0.036), and SSPG (r = 0.20, P = 0.012). In the highest versus lowest % body fat quintile, adipose cell size increased by only 7%, whereas adipose cell number increased by 74%. Conclusions: Recruitment of adipose cells is required for expansion of body fat mass beyond BMI of 25 kg/m 2. Insulin resistance is associated with accumulation of small adipose cells and enlargement of large adipose cells. These data support the notion that impaired adipogenesis may underlie insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dynamics of fat cell turnover in humans
Spalding, K. L., Arner, E., Westermark, P. O., Bernard, S., Buchholz, B. A., Bergmann, O., Blomqvist, L., Hoffstedt, J., Näslund, E., Britton, T., et al. (2008) · Nature · doi:10.1038/nature06902 · Cited by 2,357 · cited 3×
“Two studies show greater number of adipose cells in early-onset but not late-onset obese adults (4,6), and no increase in adipose cell number after puberty (6).”
BackgroundMethodRelation of Body Fat Distribution to Metabolic Complications of Obesity*
KISSEBAH, A. H., VYDELINGUM, N., MURRAY, R., EVANS, D. J., KALKHOFF, R. K., & ADAMS, P. W. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-2-254 · Cited by 1,909
Weyer, C., Foley, J. E., Bogardus, C., Tataranni, P. A., & Pratley, R. E. (2000) · Diabetologia · doi:10.1007/s001250051560 · Cited by 799 · cited 1×
“More recent clinical studies showed that larger adipose cell size is associated with systemic insulin resistance (17,18), family history of diabetes (19), and future development of type 2 diabetes (20).”
BackgroundAdipocyte Turnover: Relevance to Human Adipose Tissue Morphology
Arner, E., Westermark, P. O., Spalding, K. L., Britton, T., Rydén, M., Frisén, J., Bernard, S., & Arner, P. (2010) · Diabetes · doi:10.2337/db09-0942 · Cited by 645 · cited 1×
“More recent clinical studies showed that larger adipose cell size is associated with systemic insulin resistance (17,18), family history of diabetes (19), and future development of type 2 diabetes (20).”
BackgroundSeparation of human adipocytes by size: hypertrophic fat cells display distinct gene expression
Jernås, M., Palming, J., Sjöholm, K., Jennische, E., Svensson, P.-A., Gabrielsson, B. G., Levin, M., Sjögren, A., Rudemo, M., Lystig, T. C., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5678fje · Cited by 454 · cited 2×
“We and others (4,21-24) have now clearly shown that both large and small cells exist.”
BackgroundMcLaughlin, T., Sherman, A., Tsao, P., Gonzalez, O., Yee, G., Lamendola, C., Reaven, G. M., & Cushman, S. W. (2007) · Diabetologia · doi:10.1007/s00125-007-0708-y · Cited by 364
Self-citationMcLaughlin, T., Allison, G., Abbasi, F., Lamendola, C., & Reaven, G. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.032 · Cited by 268 · cited 1×
“The observations that 1) individuals with similar fat mass exhibit dramatic differences in insulin sensitivity (2), and 2) among IR but not insulin-sensitive (IS) individuals, dietary weight loss improves insulin sensitivity (3) suggest that biological properties of adipose tissue, independent of fat mass per se, are…”
BackgroundSelf-citationArner, P., Arner, E., Hammarstedt, A., & Smith, U. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018284 · Cited by 146 · cited 1×
“More recent clinical studies showed that larger adipose cell size is associated with systemic insulin resistance (17,18), family history of diabetes (19), and future development of type 2 diabetes (20).”
BackgroundInflammation in subcutaneous adipose tissue: relationship to adipose cell size
McLaughlin, T., Deng, A., Yee, G., Lamendola, C., Reaven, G., Tsao, P. S., Cushman, S. W., & Sherman, A. (2010) · Diabetologia · doi:10.1007/s00125-009-1496-3 · Cited by 105 · cited 2×
“It is important to note that detailed adipose cell size distributions have now been reported by a number of groups (24,31,3335), demonstrating associations with inflammation (33) and type 2 diabetes (34), as well as changes in response to overfeeding (31) and pioglitazone (24,35).”
BackgroundSelf-citation
Cited by
Adipose tissue dysfunction as determinant of obesity-associated metabolic complications
Longo, M., Zatterale, F., Naderi, J., Parrillo, L., Formisano, P., Raciti, G. A., Beguinot, F., & Miele, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092358 · Cited by 1,575
“showed that insulin-resistant individuals had larger adipocytes (50 μm fraction) in the abdominal SAT when compared with insulin-sensitive individuals [70].”
BackgroundMetabolically healthy obesity: facts and fantasies
Smith, G. I., Mittendorfer, B., & Klein, S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129186 · Cited by 645
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
Saponaro, C., Gaggini, M., Carli, F., & Gastaldelli, A. (2015) · Nutrients · doi:10.3390/nu7115475 · Cited by 529
Metabolically healthy versus metabolically unhealthy obesity
Iacobini, C., Pugliese, G., Blasetti Fantauzzi, C., Federici, M., & Menini, S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.009 · Cited by 453
Abraham, T. M., Pedley, A., Massaro, J. M., Hoffmann, U., & Fox, C. S. (2015) · Circulation · doi:10.1161/circulationaha.114.015000 · Cited by 353
Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management
Sattar, N., & Gill, J. M. R. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00326-5 · Cited by 259
Dumesic, D. A., Akopians, A. L., Madrigal, V. K., Ramirez, E., Margolis, D. J., Sarma, M. K., Thomas, A. M., Grogan, T. R., Haykal, R., Schooler, T. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2586 · Cited by 222
Metrnl: A secreted protein with new emerging functions
Zheng, S.-L., Li, Z.-Y., Song, J., Liu, J.-M., & Miao, C.-Y. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.9 · Cited by 190
Adipose tissue and metabolic syndrome: too much, too little or neither
Grundy, S. M. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12519 · Cited by 187
Endocrine-metabolic dysfunction in polycystic ovary syndrome: An evolutionary perspective
Dumesic, D. A., Abbott, D. H., Sanchita, S., & Chazenbalk, G. D. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.02.013 · Cited by 76
“Interestingly, SC abdominal adipose of normal-weight women with PCOS resembles that of overweight/obese individuals by having an increased number of small adipocytes, while lacking enlarged adipocytes as seen in overweight/obese individuals with decreased serum adiponectin levels [6, 24, 41].”
BackgroundAdipose Tissue Function in Healthy Pregnancy, Gestational Diabetes Mellitus and Pre-Eclampsia
Trivett, C., Lees, Z. J., & Freeman, D. J. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00948-9 · Cited by 65
Keller, E., Chazenbalk, G. D., Aguilera, P., Madrigal, V., Grogan, T., Elashoff, D., Dumesic, D. A., & Abbott, D. H. (2014) · Endocrinology · doi:10.1210/en.2014-1050 · Cited by 60
Varlamov, O., Bishop, C. V., Handu, M., Takahashi, D., Srinivasan, S., White, A., & Roberts, C. T. (2017) · Human Reproduction · doi:10.1093/humrep/dex244 · Cited by 34
Sex differences in androgen regulation of metabolism in nonhuman primates
True, C., Abbott, D. H., Roberts, C. T., & Varlamov, O. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_24 · Cited by 10
“Interestingly, an increase in the number of small SC adipocytes is linked with metabolic dysfunction in humans [55], as is an alternative increase in SC adipocyte size in some PCOS women [56], implying that a change in either direction away from the optimal size of SC adipocytes might have metabolic consequences.”
Background
Metadata
- Authors
- McLaughlin, T., Lamendola, C., Coghlan, N., Liu, T. C., Lerner, K., Sherman, A., & Cushman, S. W.
- Venue
- Obesity
- Publisher
- Wiley
- Published
- 2013-12-17
- Volume
- 22
- Issue
- 3
- Pages
- 673-680
- ISSN
- 1930-7381 (ISSN-L)
- 1930-739X
- OpenAlex
- W1901982314
- Cited by
- 137
- References
- 9
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.